𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hypoxia-induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro

✍ Scribed by Kirsten Sanna; Einar K. Rofstad

Publisher
John Wiley and Sons
Year
1994
Tongue
French
Weight
581 KB
Volume
58
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Rodent cell lines can develop resistance to doxorubicin and methotrexate during hypoxic stress. This has so far not been observed in human tumor cell lines. The purpose of our communication is to show that doxorubicin and methotrexate resistance can also develop in human melanoma cells during exposure to hypoxia. Four cell lines (BEX‐c, COX‐c, SAX‐c, WIX‐c) have been studied. Cells were exposed to hypoxia (O~2~ concentration < 10 ppm) for 24 hr prior to reoxygenation. Doxorubicin and methotrexate cell survival curves were determined immediately after as well as 18 and 42 hr after reoxygeation. The 4 cell lines were relatively sensitive to doxorubicin without hypoxia pre‐treatment, and all developed resistance during exposure to hypoxia. Hypoxic stress also induced methotrexate resistance in BEX‐c and SAX‐c but not in COX‐c and WIX‐c. BEX‐c and SAX‐c were sensitive to methotrexate without hypoxia pre‐treatment, whereas COX‐c and WIX‐c were resistant initially. Hypoxia‐induced drug resistance was present immediately after reoxygenation and tended to decrease with time but remained statistically significant even 42 hr after reoxygenation.

📜 SIMILAR VOLUMES

Melphalan-induced chromosome damage in s
Melphalan-induced chromosome damage in sensitive and resistant human melanoma cell lines
✍ P. G. Parsons; Leanne Morrison 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 French ⚖ 492 KB

## Abstract Twelve consecutive treatments of a human melanoma cell line (MM253) with melphalan gave a subline (MM253‐12M) which was five times more resistant to melphalan with respect to survival. In contrast to mustard‐resistant rodent cells, the MM253‐12M line had a higher stemline number than th

Multidrug resistance-1 and p-glycoprotei
Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: Expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance
✍ James J. Wyman; Abby M. Hornstein; Patricia A. Meitner; Solida Mak; Patrick Verd 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 574 KB

## Abstract We report on two chondrosarcoma cell lines, FS and AQ, that may be used as models of multidrug resistance in chondrosarcoma. Multidrug resistance‐1 expression was assayed with reverse transcription‐polymerase chain reaction. Immunostaining for the multidrug resistance‐1 product, P‐glyco

Glucocorticoid-receptor-gene defects and
Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines
✍ Monika Hala; Bernd L. Hartmann; Günther Böck; Stephen Geley; Reinhard Kofler 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 674 KB

The application of glucocorticoids (GC') in human leukemia is based on apoptosis induction but is often hampered by GC resistance. To delineate resistance mechanisms, we examined 5 GC-resistant leukemic cell lines, termed CEM-C7.RI-R5, isolated from the GC-sensitive human acute-1-cell-leukemic line,

Schedule-dependent in vitro combination
Schedule-dependent in vitro combination effects of methotrexate and 5-fluorouracil in human tumor cell lines
✍ Chun-Ming Tsai; Adi F. Gazdar; Reury-Perng Perng; Barnett S. Kramer 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 702 KB

Because of conflicting reports of clinical synergy, we used the tetrazolium-based colorimetric (MTT) assay to test in vitro combination effects of methotrexate (MTX) plus 5fluorouracil (FUra) in 4 schedules on 2 human non-small-cell lung cancer cell lines (adenocarcinoma, NCLH23; bronchioalveolar-ce

MRP gene overexpression in a human doxor
MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: Alterations in cellular pharmacokinetics and in pattern of cross-resistance
✍ Monica Binaschi; Rosanna Supino; Romolo A. Gambetta; Giuseppe Giaccone; Ennio Pr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 697 KB

## Abstract The development of non‐P‐glycoprotein‐mediated multidrug resistance is a frequent event among lung‐cancer cell lines. In an attempt to understand the underlying mechanisms of this phenotype, we have selected a multi‐drug‐resistant subline (POGB/DX) __in vitro__ for doxorubicin resistanc

Mechanism of resistance to cisplatin in
Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: Possible role of p53
✍ Faina Vikhanskaya; Luana Clerico; Monica Valenti; Maria S. Stanzione; Massimo Br 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB 👁 2 views

A possible novel mechanism of cross-resistance to cisplatin (CDDP) in the doxorubicin-resistant ovarian-cancer cell line A2780-DX3, which displays atypical multidrug resistance, is presented. A2780-DX3 is found to be more resistant than the parental line A2780 in terms of CDDP-induced cytotoxicity a